Cancer - Lectures

Closing Remarks

Novel Agents in First Line Salvage

Relapsed / Refractory HL

Toxicities with Checkpoint Inhibitor Therapy: Diagnosis, Management and Follow-up

Immunotherapy – Clinical

Checkmate 205: Cohort D

Immunotherapy – Clinical

Functional and Financial Outcomes after Treatment for Pediatric Hodgkin Lymphoma

Pediatric HL

Genotyping in Familial HL

Pediatric HL

PD1 /-L1 Expression in Pediatric HL

Pediatric HL

LYSA AHL2011 Phase III Study

Advanced Stages

HD18 Update

Advanced Stages

ECHELON1 Update

Advanced Stages

Genetic Susceptibility

Survivorship & Patient Perspectives

Cognitive Behavioral Therapy for Fatigue in HL

Survivorship & Patient Perspectives

What Patients Really Want: The Global Lymphoma Patient Survey

Survivorship & Patient Perspectives

BREACH: Randomized Phase II Trial

Early Stages

Early-Stage Favorable HL: HD16

Early Stages

Genotyping of cHL via Liquid Biopsy

Biology & Microenvironment

Microenvironment

Biology & Microenvironment

Progress on anti-PD1 moAb

Interactive Case Discussion

HIV-positive HL

Interactive Case Discussion

Elderly cHL

Interactive Case Discussion